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HIV dynamics within the host are complex especially when a reservoir of
latently infected CD4+ T cells are present. The failure of the immune system
and antiviral therapy to suppress the virus has been suggested to be enhanced
by the latently infected CD4+ T cells which are responsible for persistence
of HIV within the host. Cells remaining in latent state have been shown to
lack sufficient levels of Tat and associated activation-dependent host factor
that are necessary for processive transcription of the virus. Tat is a protein
that is capable of activating the latently infected CD4+ T cells. Recently, as
a protein, Ssu72 was found to be responsible for activation and replication
of the virus. Ssu72 enhances the effects of Tat activation in a mutualistic
interactive manner. The interaction of Tat and Ssu72 thus, enhances the
activation of the latently infected CD4+ T cells which may in turn expose
the virus for possible attack by the immune system reaction. In the current
study, we modify a constant virus HIV model to incorporate the effects of Tat
and Ssu72 on latently infected CD4+ T cells. We analyze the models using
both analytic and numerical techniques. Important threshold was derived
and model analysis carried out. The incorporation of Tat and Ssu72 proteins
on the HIV-1 model with a constant virus shows that, with time the unifected
and infectious classes decrease to zero for a threshold value of 30-40 copies
of each protein.
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In 2013, South Africa was estimated to be the leading country in cases of
people living with HIV-1. About 6.3 [6-6.5] million cases of people living
with HIV-1 [1] and about 200,000 [170,000 - 220,000] death due to AIDS [1]
were estimated in South Africa. In 2014, 36.9 million [34.3 million - 41.4
million] people globally were living with HIV. According to the 2014 global
statistics by UNAIDS, the new HIV infection have fallen by 35% since 2000.
However, there have been 2 million [1.9 million - 2.2 million] new cases re-
ported of people infected with HIV [2]. Despite the existence of intervention
strategies, there has been new cases of people living with HIV-1 reported [21].
HIV-1 is a virus that attack immune system making it weak to fight off any
infections [19]. HIV-1 is described by a progressive loss of CD4+ T cells, as
well as excessive immune activation and poor control of the virus by T cells in
1
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most individuals [14]. This has led to many studies conducted to understand
the dynamics of the virus. However, there exist no vaccine for HIV up to
date [17]. Hence, if an individual has acquired the virus, the subject remains
with it not cured but only treated. The antiretroviral treatment is one of
the intervention strategies that has to be initiated to the infected subject [21].
Due to a statistical increase in new cases of people living with HIV-1, the
roll-out or distribution of ARVs had to increase. But the distribution of
the drug is costly [22], which calls for new intervention treatment strategies.
In most Sub-Saharan countries an individual initiates ARV when the sub-
ject’s CD4 count is 200 cell/µl or less [17, 22]. Most studies have disputed
this threshold. An estimate of 42% of people living with HIV in developing
countries have access to ARVs [22]. The high active anteretroviral treatment
(HAART), helps the immune system to effectively suppresses the virus repli-
cation [4]. This leads to the increase of the number of CD4+T-lymphocyte,
which directly leads to a degree of immune reconstitution that is sufficient
to reverse clinically apparent immunedeficiency [4].
The murine and animal models have shed light on the importance of CD4+
T helper cells in the control of chronic viral infection [11]. These results
revealed the importance of CD4+ T cells and CD8+ T cells interplay in the
maintenance of potent and effective immune response that is able to control
chronic viral infections [4, 11]. According to [22], the CD4+ T helper cell
responses are essential for eliminating virus during the acute phase of dis-
ease and must be permanently maintained to achieve long-time viral control
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[4, 11, 19]. The depletion of CD8+ T cells in chronical phase lead to increase
in viral load [11], which progressively leads to viral replication that in turn
further impairs the functionality of immune system.
According to the report on CD4+ T cell count in HIV patients [19], HIV
primary target immune cells called CD4+ T cells. These are type of T-
lymphocyte (white blood cells) that help coordinate immune system’s re-
sponse to infection and disease. They use a molecule called CD4 on their
surface to detect foreign substances. HIV-1 infects the CD4+ T cells through
first binding to the receptors on CD4+ T cells. This phase in which the virus
begins to replicate is known to be acute infection. The rapid replication of
the virus causes the reduction in CD4+ T cells.
Despite the robust response of immune system and initiation of treatment
(HAART) by an infected individual, HIV-1 still persist in an infectious state.
The challenge to curing HIV infection lies on the power of HIV to patiently
wait in the infected subject before it makes more copies of itself. This virus
rest in CD4+ T cells to develop latent reservoirs that are usually established
a few days after the duration of the HIV-1 infection. The challenge to eradi-
cation of the virus in an infected individual, lies in the clearing of the latent
reservoirs. In recent studies, it has been shown that the eradication of the
virus can be achieved through reactivation of latent HIV-1.
The latent reservoir is established a few days after a duration of infection
on an infected individual [6, 7]. In the study by Williams S. A. et al. [6],
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these latently infected cells are then activated due to exposure of their cellu-
lar host to selected cytokines, and they continue repopulating during active
viral replication. The long-lived cells persist regardless of antiviral therapy
consumed by an infected individual [8], hence the long-term use of the an-
tiviral therapy has failed to eradicate the virus in an infected individual [7].
The failure of HAART to cure HIV-1, lies in the latently infected CD4+ T
cells, that provide a reservoir for HIV-1. HAART only keeps the HIV-1 in-
fection to a chronic infectious stage, which implies that it only inhibits the
initiation of new infection cycle of the virus produced from cellular reservoir
[8]. Thus, clearing of latent reservoir is of interest in inventing strategies that
will completely eradicate the virus from an infected individual.
The latent state of infection result from the fact that some activated CD4+ T
cell reverse the state of virus replication to return to resting state and persist
as memory cells [9]. These cells will only produce the virus when they are
activated, hence when they are in latent state, they wait patiently and unde-
tectable even by HAART for a chance to reproduce. The long life span and
slow decay rate of the latent CD4+ T cells guarantees lifetime persistence of
these cells [9, 10]. Thus there must exist factors that influence activation of
these cells. Lassen K et al. [9], state that the resting cells lack the sufficient
level of HIV-1 Tat and Tat-associate activation-dependent host factor that
are necessary for processive transcription.
Recently, it has been discovered that it is not only the T-cells that drive the
dynamics of HIV-1 but also the existence of the protein called Tat. According
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to the Salk team (2014), HIV-1 cannot live without the existence of Tat. The
Tat protein serves as a HIV-1 scout for suitable environment for the virus
to replicate [18]. As a result when the environment has been discovered,
only then it kicks off the HIV’s transcription to enable the virus to replicate
and spread [18]. In a recent study by Chen Y. et al. [23], a protein named
Ssu72 was demonstrated to play a key role through interacting with Tat, in
activation of the resting virus, by binding directly to Tat and also building
a feedback loop to speed up the process of replication [18].
1.2 Research question
What is the effect of Tat and Ssu72 on the activation of latently infected
CD4+ T cells and on the response of immune system?
1.3 Problem statement
The recent discovery of Ssu72 protein by Chen Y. et al. [23], known to be a
partner to Tat protein is assumed to play a key role in activation and repli-
cation of HIV-1. It is assumed that the interplay between the two proteins
might play a crucial role in activating the latently CD4+ T cells. In this
study we look at the contribution of the two proteins in the dynamics of
HIV, specifically the resting virus in CD4+ T cells, whether the two proteins
enhance the activation of latent virus or not. The study of these proteins
might play a critical role in the integration of treatment.
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1.4 Aim
The aim of this study is to investigate if the activation of latently infected
CD4+ T cells by Tat and Ssu72 clears the latent reservoirs through the im-
mune response.
1.5 Objectives
1. To use the in-host model to capture the dynamics of HIV infection.
We shall capture the dynamics of Tat and Ssu72 using a mutualistic
system of two equations.
2. To use the in-host HIV infection model with a constant virus produc-
tion, incorporated with the dynamics of Tat and Ssu72 to capture and
analyze the effects of the two proteins on latently infected CD4+ T
cells.
3. To use mathematical theories and spectral based methods to analyze
the in-host HIV infection model with constant virus production incor-
porated with Tat and Ssu72.
1.6 Significance of the study
The importance of this study is understanding the impact of Tat and Ssu72
proteins on the persistent HIV-1 infection as well as the influence of Tat and
Ssu72 proteins on the activation of the latent HIV-1 and replication of the
virus. This study might possibly lead to the development of better strategies
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against HIV-1. The study will pave a way for future studies aimed to mod-
ify intervention strategies to eradication of HIV-1 infection in an infected
subject.
1.7 Scope of the study
In this chapter we have discussed the background of the study, presented a re-
search question, problem statement, aim and objectives, and the significance
of the study. The rest of the dissertation is organized as follows. Chapter
2 presents a literature review of the topic, we first give the introduction of
HIV-1 infection dynamics, a brief description of Tat and Ssu72 proteins and
a brief discussion on preliminaries. In chapter 3 we formulate and analyze
the HIV-1 model with a constant virus, followed by the HIV-1 model incor-
porating Tat and Ssu72 proteins in chapter 4. In chapter 5 we present and
discuss numerical results of the two model as well as conclusions.
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Literature Review
2.1 Introduction of HIV-1 infection dynamics
Human Immunodeficiency type 1 (HIV-1) is a virus that infect and weak-
ens the human immune system and CD4+ T cells are the main target of
this virus. Hence, HIV-1 infection is characterized by the absence of HIV-1
specific CD4+ T helper cell responses, and in turn resulting in disease pro-
gression [11]. F. Chirove and E. Lungu (2013), mentioned that matured HIV
particles inside actively infectious CD4+ T cell leave the cell through bud-
ding or by lysing the host cell to infect more targets. This process produces
more viral particles which continues to fight immune response and finally
defeating the immune system. Without treatment, HIV infection can pro-
gressively result in a deadly stage of Acquired Immunodeficiency syndrome
(AIDS). HIV/AIDS infection is characterized by four basic stages, namely,
seroconversion and primary HIV infection, chronic HIV infection, the pre-
AIDS stage, and the AIDS stage [3, 19].
8
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T-cells are type of white blood cells that play an important role in the body’s
immune system [13]. These type of cells develop from liver or bone marrow
stem cells that mature in the thymus [16]. These cells play a major role in
cell mediated immunity. They contain protein called T-cell receptors that
populate the cell membrane [15]. These receptors are capable of recognizing
various types of antigens. There exist three primary classes of T-cells that
play specific role in the destruction of antigens, namely, cytotoxic T cells,
helper T cells and regulatory T cells [15]. There are two main types of T-cell
which are of interest in the dynamics of HIV-1, namely, CD4+ T and CD8+
T cells. CD4+ T cells have the glyco-protein called CD4 on their surface
[16]. These cells are known to be the helper cells and to initialize the body’s
response to infection. Where as CD8+ T cells have a glyco-protein called
CD8 on their surface [16]. CD8+ T cells are known to be killer cells, and
they produce antiviral substances (antibodies) that help fight off the foreign
invader.
According to Altfeld and Rosenberg (2000), antigen-specific CD4+ T cell play
a vital role in control of chronic viral infection. The critical importance of
CD4+ T helper cell responses is maintaining cytotoxic T lymphocyte (CTL)
function. CD4+ T cells play a critical role in maintenance of CTL responses
during the chronic phase of infection. In the absence of sufficient CD4+ T
cells help, antiviral CTLs persist in an inactive state. Hence, CD4+ T helper
cell and CD8+cytotoxic T cell responses are essential for the maintenance of
effective immunity in chronic viral infections.
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A number of HIV models only account for the acute and asymtomatic la-
tency phase and cannot explain the progression to AIDS [28]. S. Alizon
and C. Magnus (2012) review a few number of HIV models and discuss the
robustness of the biological hypotheses of these models. The hypotheses of
interest were; virus diversity, loss of immune cells, phenotypic switches. They
found that the advance models compared to basic models gave more infor-
mation to test hypotheses that can explain the onset of AIDS [28]. However,
amongst these methods, they failed to find (understand) factors that lead
to the onset of AIDS. Though a vast numbers of HIV model (played a vi-
tal role in treatment development) have been established, but Perelson et al.
[28] suggest a need of models explaining the whole dynamics of HIV infection.
F. Chirove and E. Lungu (2013), studied the one strain model of HIV infec-
tion by looking at the cell-free infection mechanism under the assumption of
constant viral production and density dependent viral product mechanism.
The treatment was imposed on the cell-to-cell infection mechanism. Through
the use of mathematical techniques, conclusion were taken regarding the ef-
fects of treatment on the cell-to-cell mechanism, and the incorporation of
a constant and density dependent viral production. The benefit of initi-
ation of treatment before the threshold of developed AIDS (CD4+ T cell
count < 200 mm−3) were shown. Amongst these benefits, they mention,
the restoration of immune system’s strength, depletion of viral production to
undetectable levels and reduction of severity of the infection.
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A. S. Perelson and R. M. Ribero (2013), review development of HIV model-
ing, emphasizing qualitative findings about HIV biology uncovered by study-
ing acute infection, the response to drug therapy and the rate of generation
of HIV variant that escape immune response. They mention factors that
contribute in progression of the infection (even for patients in ARVs), which
are, latent reservoirs and drug resistance. They also mention factors that
contribute to resistance and the diversity of HIV, which are, high rate of
mutation of virus, its fast life cycle and the long-term nature of HIV infec-
tion. In their study they suggest that development of a vaccine that prevents
infection in the first course of disease is very important.
2.2 HIV-1 Tat
Trans-Activating Transcription (Tat) is a regulatory protein produced very
early after the HIV infection, necessary for viral gene expression, cell-to-cell
virus transmission and disease progression and can be released extracellularly
by leaderless secretory path, even during anti-retro-viral therapy [24, 25].
According to Lassen K. et al. [9], Tat is synthesized early after a subset of
multiply joined viral RNA species. Tat is essential for HIV-1 replication. Ac-
cording to Watson and Edwards (1999), during the initial phase of infection,
large amounts of Tat, together with other regulatory protein, are synthesized
and drive HIV-1 replication [24]. Tat has a remarkable property, it can leave
cells from which it is synthesized and cross the cell membrane of adjacent
cells, where it localizes in the nucleus [24].
Page 11 of 83
Chapter 2 2.3. Ssu72 Protein
Tat maintains its activity and, once inside the nucleus, is able to trans-
activate a number of genes, especially those relating to cytokine production,
and thus can modulate certain cellular activities [24]. These cellular activities
are viral gene expression. Tat achieves this process through binding with
RNA, acting as a level of elongation [9]. Tat is a potent trans-activator of
HIV-1, and is also able to trans-activate other genes. Trans-activation by
Tat is entirely dependent upon the presence of TAR RNA, a transcription
control element that appears to be unique to lentiviruses [24]. Extracellular
Tat leaves the host cell to enter the adjacent cells, resulting in the activation
of resting cell, suggesting that Tat plays an important role in the chronic
immune activation present during the HIV infection. According to Nicoli F.
et al. [25], Tat is shown to play a vital role in the proliferation of CD8+ T
cells.
2.3 Ssu72 Protein
The protein Ssu72 also plays a crucial role in speeding up the process of HIV-
1 replication. It is essential for Tat:P-TEFb-mediated phosphorylation of the
S5P-CTD [23]. Ssu72 also stimulates nascent HIV-1 transcription in phos-
phate dependent manner by synergizing with Tat in a phosphate dependent
manner to activate transcriptional from integrated HIV-1. The interaction
between the two proteins can be thought as Tat being an engine for HIV
replication and Ssu72 revs up the engine [18].
The knock down of Ssu72 impairs Tat transcription. Due to a fact that Ssu72
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is recruited by Tat to the integrated HIV-1 proviral promoter in TNF-α, and
also the direct interaction between Tat and Ssu72 which strongly stimulates
Tat CTD phosphate activity [23]. The important role of Ssu72 is through
binding to Tat which not only activates the transcription, but also builds the
feedback loop to speed up the the process. Unlike the protein CycT1 (Tat’s
partner), Ssu72 is not commonly required for cellular gene transcription,
which makes it a useful target to selectively disrupt viral gene expression in
infected cells [18].
Most trusted methods for numerical simulation in analysis of initial value
problems (IVP) have been MatLab ode solvers such as, ode45, ode113 and
ode23. Recently, Motsa et al. [40, 41, 42] have shown an interest in develop-
ing spectral based methods, to solve chaotic systems, such as, Lorenz, Chen
and Rikitake. In 2012 they presented a multistage successive linearisation
method (MSLM) which was super succeeded by the multistage spectral relax-
ation method (MSRM). These methods solve large interval IVPs by dividing
the interval into small sub-intervals. In this study we apply the MSRM to
solve the model incorporating Tat and Ssu72. The MSRM was found to be
reliable and accurate through the comparison with built-in MatLab based
ode45 solver [40, 42].
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2.4 Preliminaries
2.4.1 Existence of solutions [29]
Consider
ẏm = fm(t, y1, . . . , yn), with m = 1, . . . , n (2.1)
subject to initial conditions ym = ym0 and t = t0. The region D (a paral-
lelepiped in n + 1 dimension) is defined by t0 ≤ t ≤ t0 + h, |ym − ym0| ≤
km(m = 1, . . . , n) where h < km/M, M being bound for fm, i.e |f | < M .
Theorem 2.4.1. {Existence Theorem}: Let fm(t, y1, . . . , yn) be a single-
valued continuous function of t, y1, . . . , yn in D such that for m = 1, . . . , n
(a) |fm(t, y1, . . . , yn)| < M in D
(b) (Lipschitz condition)
|fm(t, y1, . . . , yn)− fm(t, y′1, . . . , y′n)| < K1|y1 − y′1|+ . . .+Kn|yn − y′n|,
K1, . . . , Kn being finite constants, for any (t, y1, . . . , yn) and (t, y
′
1, . . . , y
′
n) in
D. Then, for h < km/M (m = 1, . . . , n), the system (2.1) possesses one and
only one set of continuous solution y1(t), . . . , yn(t) in t0 ≤ t ≤ t0 + h such
that ym(t0) = ym0(m = 1, . . . , n).
2.4.2 Equilibrium state [29]
Consider a nonlinear dynamical system
ẏ = f(t, y), y ε Rm. (2.2)
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Definition 2.4.1. a ∈ Rm is an equilibrium state for (2.2) if f(t, a) = 0, for
all t.
Remark. If the dynamical system is initialised at an equilibrium state, then
it stays there, that is, if x(t0) = a, then x(t) = a for all t ≥ t0.
2.4.3 Stability [29]
Definition 2.4.2. An equilibrium state x∗ = a is said to be:
(a) Stable if for any positive scalar ε there exist a positive scalar σ such that
‖x(t0)‖ < σ, ‖x(t)‖ < ε for all t ≥ t0,
(b)Asymptotically stable if it is stable and if in addition x(t) → x∗ as
t→∞,
(c) Unstable if it not stable, that is, there exist an ε > 0 such that for every
σ > 0 there exist an x(t0) with ‖x(t0)‖ < σ, ‖x(t1)‖ ≥ ε for some t1 > t0.
There exist several method that can be use to analyse the stability of an equi-
librium state, namely, Liapunov function, center manifold theory, Jacobian
(eigenvalue) and Routh Hurwitz stability criterion.
2.4.4 Center manifold theorem [31]
Theorem 2.4.2. Consider the following general system of ordinary differ-
ential equations with a parameter φa
dx
dt
= f(x, φa), f : Rn × R→ R and f ∈ C2(Rn × R). (2.3)
Without loss of generality, it is assumed that 0 is an equilibrium for system
(2.3) for all values of the bifurcation parameter φa, that is f(0, φa) = 0 for
all φa and we assume
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is the linearization of the system (2.3)
around 0 with φa evaluated at φ
∗
a. Zero is a simple eigenvalue of A and
the eigenvalues of A have negative real part.
• Matrix A has a right eigenvector w and a left eigenvector v correspond-
ing to the zero eigenvalue.
The local dynamics of (2.3) around 0 are totally governed by a and b, where

















1. a > 0, b > 0. When φa < 0 with |φa|  1, 0 is locally asymptotically
stable, and there exists a positive unstable equilibrium; when 0 < φa 
1, 0 is unstable and there exists a negative and locally asymptotically
stable equilibrium;
2. a < 0, b < 0. When φa < 0 with |φa|  1, 0 is unstable; when
0 < φa  1, 0 is locally asymptotically stable, and there exists a positive
unstable equilibrium;
3. a > 0, b < 0. When φa < 0 with |φa|  1, 0 is unstable, and there
exists a locally asymptotically stable negative equilibrium; when 0 <
φa  1, 0 is stable, and a positive unstable equilibrium appears;
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4. a < 0, b > 0. When φa changes from negative to positive, 0 changes its
stability from stable to unstable. Correspondingly a negative unstable
equilibrium becomes positive and locally asymptotically stable.
2.4.5 Descartes rule of signs [30]
The Descartes’ rule of signs is a method for finding the number of roots and






n−k, k = 0, 1, . . . , n (2.5)
be a polynomial function of order n and ak are real constant. The function
P (x) has n complex solutions thanks to the fundamental theorem of algebra.
Then the general concept regarding Descartes’ rule of signs for finding signs
of roots is given as follows,
• The number of positive real zeros of P is either equal to the number of
variations in sign of P (x) or less than this by an even number.
• The number of negative real zeros of P is either equal to the number
of variation in sign of P (−x) or less than this by an even number.
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HIV-1 model with a constant
virus production
3.1 Introduction
In this chapter we formulate and analyze the model with a constant virus
production. This model shall capture the dynamics of five classes of HIV-1.
We use analytic strategies such as feasible region, equilibrium points and
stability analysis to study the behavior of the model.
3.2 Model formulation
In this study we extend one strain model with constant virus production
[17], to incorporate the role of trans-activating transcription (Tat), Ta, and
Ssu72, Su on the dynamic of HIV-1. The constant virus production model
consist of five classes , namely, uninfected CD4+ T cells population, T , la-
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tently infected CD4+ T cells population, IL, active infected CD4
+ T cells
population, IA, virus population, VI , and the CD8
+ T cells population, Z.
The two proteins to be incorporated have been shown to play a vital role in
activation of latently infected cells and replication of HIV-1.
We assume that recruited CD4+ T cells from the thymus enter the T class at
a constant rate π and die naturally at a constant rate µ. The CD4+ T cells
can be infected with the virus at a constant rate β. Thus the rate of change
of CD4+ T cells is given by
dT
dt
= π − µT − βTVI . (3.1)
Throughout the infectious phase not all CD4+ T cells are actively infectious.
Some CD4+ T cell will at this stage be latently infected and some will be
actively infectious. Thus, a proportion α of infected cells become latently
infected and (1 − α) become actively infectious. The latently infected cells
can be activated into actively infectious cells at a constant rate γ and die
naturally at a constant rate µ. Thus the rate of change of latently infected
CD4+ T cells population is given by
dIL
dt
= αβTVI − (µ+ γ)IL. (3.2)
The actively infectious CD4+ T cells die naturally at a constant rate µ and die
at a constant rate, ω, due to lysis caused by the virus. The actively infectious
CD4+ T cell also die at a constant rate σ due to the killing by CD8+ T cells.
The rate of change of actively infectious CD4+ T cells population is given by
dIA
dt
= (1− α)βTVI + γIL − (µ+ ω)IA − σIAZ. (3.3)
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We assume that each actively infectious CD4+ T cell produces an average of
N viral particles. The viral particles produced by these cells occur at a rate




= ωNIA − µvVI . (3.4)
We suppose that CD8+ T cells are recruited from thymus at a constant rate
of π1 and die naturally at a rate µ1. The CD8
+ T cells are also produced
proportionally to the presence of infected CD4+ T cells at a rate β1. The
rate of change of CD8+ T cells is then given by
dZ
dt
= π1 + β1IA − µ1Z. (3.5)
The in-host dynamics of the HIV infection is represented by the model dia-
gram shown in Figure 3.1
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Figure 3.1: Model showing the interaction of the compartments
3.3 Feasible region of the model
We proceed to analyse the behavior of the model constructed in section
3.2. We shall determine the existence of solutions, calculate the equilibrium
points, calculate the basic reproduction number and carry out stability anal-
ysis of equilibrium point in our model analysis.
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For analysis of the model, we need to have a feasible region, where the model
will be biological meaningful. We denote the feasible region by Λ0 and define
it so that it will be positively invariant. The positive invariance ensures that
the positive solutions are both mathematically and biologically meaningful.
Thus, the population considered in the system of equations (3.1)-(3.5) are
















T (0) > 0, IL(0) ≥ 0, IA(0) ≥ 0, VI(0) ≥ 0 and Z(0) > 0. (3.7)
Theorem 3.3.1. The feasible region Λ0 with initial conditions (3.7) is pos-
itively invariant.
Lemma 3.3.2. If T (0) > 0, IL(0) ≥ 0, IA(0) ≥ 0, VI(0) ≥ 0 and Z(0) >
0 then T (t) > 0, IL(t) ≥ 0, IA(t) ≥ 0, VI(t) ≥ 0 and Z(t) > 0.
Proof. First we show that the solutions of systems of equations (3.1)-(3.5) are
positive. We proceed by contradiction (proof by contradiction). Assume that
∃ t1 < t such that T (t) ≤ 0, IL(t) ≥ 0, IA(t) ≥ 0, VI(t) ≥ 0 and Z(t) > 0.
Let T (t1) = 0 first,
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Then (3.1) becomes
Ṫ = π, (3.8)
⇒T (t) = π(t− t1). (3.9)
Thus, T (t) > 0, ∀ t1 < t which contradicts our assumption. Therefore, there
exist no T (t) ≤ 0 ∀ t1 < t. Hence, Lemma 3.3.2 is true.
Now, (3.2) becomes
İL = −(µ+ γ)IL, T (t1) = 0, (3.10)
⇒IL(t) = IL(t1)e−(µ+γ)(t−t1) > 0, ∀ t1 < t. (3.11)
In the same manner it can be shown that when T (t1) = 0, (3.3)-(3.5) become;
IA(t) =
γIL


















Thus (3.12)-(3.14) are all non-negative ∀ t1 < t provided IA(t1) > 0, VI(t1) >
0, Z(t1) > 0, respectively. The same can be done for the cases where we
choose at least one of the state variables at time t1 to be negative. The
similar conclusion is reached, that is, the solutions for (3.1)-(3.5) remain in
the positive region ∀ t with respect to non-negative initial conditions, i.e.,
(3.7). Thus, the Lemma 3.3.2 is true.
Lastly, we show that the solutions have an upper bound. Let Tt = T+IL+IA
such that Tt(0) > 0. Then
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= π − µ(T + IL + IA)− ωIA − σIAZ,


















The population of Tt cannot exceed the value
π
µ
, hence the population Tt is









By the boundedness of IA,
ωNIA ≤ ωN πµ , (3.18)





− µvVI . (3.20)
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Using the same approach above it can be shown that
dZ
dt


















Z ≤ µπ1 + βπ
µµ1
. (3.25)




Since the solutions of (3.1)-(3.5) are positive and bounded, therefore we
conclude that the feasible region Λ0 with initial conditions, (3.7), is positively
invariant.
3.3.1 Disease free equilibrium point
The disease free equilibrium point (DFE) is the state in which there exist no













In the next subsection 3.3.2 we introduce the concept of the basic reproduc-
tion number and the use of it.
3.3.2 Basic reproduction number
The basic reproduction number, R0, is referred to as the expected number of
secondary infections produced by an index case in a completely susceptible
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population [32, 33]. In an in-host dynamics, R0 gives the number of newly
infected cells produced by one infected cell during its lifetime, assuming all
other cells are susceptible [32]. It follows then that, if R0 < 1, then a few
infected individuals introduced into a completely susceptible population will,
on average fail to replicate themselves, and the disease will not spread [34].
If R0 > 1, then the number of infected CD4
+ T cells will increase with each
generation and the disease will spread [34].
The derivation of the basic reproduction number is based on the lineariza-
tion of the ODE model about a disease free equilibrium [34]. There are five
assumptions based on the construction of R0, see [33, 34]. The basic repro-
duction number is defined mathematically as the spectral radius of the next
generation matrix C = FV −1 denoted as
R0 = ρ(C), (3.27)
where F denotes the (n× n) matrix of secondary (new) infection and V de-
notes an (n × n) matrix of disease progression, death and recovery [34]. In
general R0 is an eigenvalue of C and is strictly larger in modulus than all
other eigenvalues of C [33, 34].
To calculate the basic reproduction number, we identify the infected classes
and from those infected classes we extract F and V . Now, from equations






 , V =

(µ+ γ)IL
−γIL + (µ+ ω)IA + σIAZ
−ωNIA + µvVI
 . (3.28)
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0 0 (1− α)βT0
0 0 0
 , V = ∂V∂xi =

µ+ γ 0 0











(µ+ γ)(µ+ ω + σZ0)
1
(µ+ ω + σZ0)
0
γωN
µv(µ+ γ)(µ+ ω + σZ0)
ωN



















µv(µ+ γ)(µ+ ω + σZ0)
, a2 =
βωNT0





The basic reproduction number, which is defined as the spectral radius of
the next generation matrix FV −1 can be determined as follows. The three
eigenvalues of the matrix FV −1 are
λ0,1 = 0, and λ2 =
γαωNβT0
µv(µ+ γ)(µ+ ω + σZ0)
+
(1− α)ωNβT0
µv(µ+ ω + σZ0)
. (3.32)
λ2 is the largest eigenvalue and hence, the reproduction number is given by
R0 =
γαωNβT0
µv(µ+ γ)(µ+ ω + σZ0)
+
(1− α)ωNβT0
µv(µ+ ω + σZ0)
. (3.33)
Page 27 of 83
Chapter 3 3.4. Endemic equilibrium point
The numerator on the reproduction number is composed of the rates in which
the infection keeps persisting, i.e, the rate of activation of latently infected
cells to be actively infectious and the rate at which the virus is produced.
Where as the denominator is composed by the rates of death of cells and
infection.
3.4 Endemic equilibrium point
To attain the endemic equilibrium points we set the right hand side of the
system of equations (3.1)-(3.5) to zero.
π − µT ∗ − βT ∗V ∗I = 0, (3.34)
αβT ∗V ∗I − (µ+ γ)I∗L = 0, (3.35)
(1− α)βT ∗V ∗I + γI∗L − (µ+ ω)I∗A − σI∗AZ∗ = 0, (3.36)
ωNI∗A − µvV ∗I = 0, (3.37)
π1 + β1I
∗
A − µ1Z∗ = 0. (3.38)
Using equations (3.35) and (3.37) we rewrite equation (3.36) in terms of I∗A






− (µ+ ω + σZ∗)
)
I∗A = 0. (3.39)
The resulting solutions from (3.39) are,
I∗A = 0, and T
∗ =
µv(µ+ γ)(µ+ ω + σZ
∗)
ωβN [(1− α)(µ+ γ) + αγ]
.
Note that when I∗A = 0 we obtain the disease free equilibrium point. There-
fore, the endemic equilibrium point will be given by T ∗. Since from (3.38)
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ωβN [(1− α)(µ+ γ) + αγ]
. Therefore, I∗L and V
∗


















. If we now substitute, T ∗ and V ∗I into (3.34) to solve for
















(R0−1) = 0. (3.44)
To solve for I∗A we consider the following three cases for which we must attain
a positive solutions for an endemic equilibrium point.
Theorem 3.4.1. The endemic equilibrium point E11 exists only when R0 >
1.
Proof. Consider the following cases
Case 1: R0 < 1
If R0 < 1, then by the Descartes’ rule of signs, (3.44) have two negative real
roots. Since the two roots have no biological meaning, then we disregard the
case where R0 < 1 for the existence of positive solution.
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Case 2: R0 = 1
When R0 = 1 we have that













We therefore disregard the negative solution.
Case 3: R0 > 1
In this case, by the Descartes’ rule of signs, (3.44) we have one positive real
root and one negative real root. Since the negative root has no biological
meaning and fails the assumption of positive invariant set Λ0, it is for this
reason that it is disregarded. Thus, I∗A for an endemic equilibrium is given





































I , and Z
∗ are given in equations
(3.41), (3.42), (3.45), (3.43), and (3.40), respectively.
3.5 Stability analysis of equilibrium points
In this section we analyze the stability of both the disease free and the en-
demic equilibrium points.
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3.5.1 Local stability of DFE
To prove the local stability of the disease free equilibrium point, the Routh-
Hurwitz stability criterion method is used. For local stability of DFE, we
shall show that all the eigenvalues associated with the DFE are negative.
Theorem 3.5.1. The disease free equilibrium of the system, (3.1)-(3.5), is
locally asymptotically stable if R0 < 1 and unstable when R0 > 1.
Proof. To find the first three eigenvalues, we use a (3× 3) matrix extracted
from the Jacobian matrix evaluated at the DFE. Routh-Hurwitz stability
criterion is then used to find necessary condition for the eigenvalues to be
negative real and for the DFE to be asymptotically stable. The (3×3) matrix
is
F − V =

−(µ+ γ) 0 −βπ
µ






The eigenvalues λ of F −V are the solutions of the characteristic polynomial
det((F − V )− λI) = 0, where I is the (3× 3) identity matrix. This gives
λ3 + b1λ
2 + b2λ+ b3 = 0, (3.47)
with
b1 = (2µ+ γ + µv + ω + σZ0),
b2 = [(µ+ γ + µv)(µ+ ω + σZ0) + µv(µ+ γ)− (1− α)ωβNT0],
b3 = µv(µ+ γ)(µ+ ω + σZ0)(1−R0).
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By the Routh-Hurwitz conditions, equation (3.47) has negative roots if
b1 > 0, b3 > 0, b1b2 − b3 > 0.
Clearly, b1 > 0 and b3 > 0 when R0 < 1. The condition
b1b2 − b3 =(2µ+ γ + µv + ω + σZ0)[(µ+ γ)(µv + ω + σZ0)+
µv(µv + ω + σZ0)− (1− α)ωβNT0] + µv(µ+ γ)[(2µ+ γ) + (µv + ω + σZ0)R0]
=(2µ+ γ + µv + ω + σZ0)
[
(µ+ γ)(µv + ω + σZ0)+
µv(µv + ω + σZ0)
(
1− γαωNβT0
µv(µ+ γ)(µ+ ω + σZ0)
− (1− α)ωNβT0
µv(µ+ ω + σZ0)
+
γαωNβT0
µv(µ+ γ)(µ+ ω + σZ0)
)]
+ µv(µ+ γ)[(2µ+ γ) + (µv + ω + σZ0)R0]
=(2µ+ γ + µv + ω + σZ0)
[
(µ+ γ)(µv + ω + σZ0)+





µv(µ+ γ)[(2µ+ γ) + (µv + ω + σZ0)R0]
>0
when R0 < 1. Since all the three conditions are satisfied we conclude that
the three eigenvalues from a matrix (3.46) are all non-positive.
The other two eigenvalue are
λ1 = −µ < 0, (3.48)
λ2 = −µ1 < 0. (3.49)
Hence, by the Routh-Hurwitz criterion the disease equilibrium point is asymp-
totically stable when R0 < 1. On the other hand when R0 > 1, there exist
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one positive root and four negative roots, implying that we have an unstable
DFE.
3.5.2 Global stability of the DFE
In order to study the global stability of the equilibrium, we use the Lyapunov
method. This method seek for a function which shall satisfy some necessary
and sufficient conditions, to ensure the global stability of an equilibrium.
Suppose the Lyapunov function, denoted as U is continuously differentiable
in the set D, then the necessary and sufficient conditions for global stability
of an equilibrium x∗ = 0 are
1. U(0) = 0
2. U > 0,∀x ∈ D − {0}
3. U̇ < 0.∀x ∈ D − {0}.
(3.50)
Theorem 3.5.2. The disease free equilibrium is globally stable if R0 < 1.
Proof. Consider the corresponding Lyapunov function defined as
U =
(











Equation (3.51) by definition is positive definite. Using the chain rule, the
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where the dot defines the derivative with respect to time, t. Substituting,






(π − µT − βTVI) + c1(αβTVI − (µ+ γ)IL)+
c2((1− α)βTVI + γIL − (µ+ ω)IA − σIAZ)+





(π1 + β1IA − µ1Z).
(3.53)
From (3.53) we extract coefficients of all linear terms associated with the
infectious classes in equation form and equate them to zero to solve for,
c1, c2 and c3. Thus,
c2γ − (µ+ γ)c1 = 0, (3.54)
β1 + c3ωN − c2(µ+ ω) = 0, (3.55)
βT0 − c3µv = 0. (3.56)













If we now substitute π = µT0, π1 = µZ0, and compactly rewrite (3.53) in
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terms of c2, we obtain
U̇ =− µ
T



























To find the condition that guarantees (3.57) to be negative definite, we con-
















If we let c5 =







, then (3.58) can be written as
follows
c4 = c5R0.
Since c5 > 1, and we require that c4 − 1 < 0, then c4 − 1 = c5R0 − 1 < 1
implies R0 < 1/c5 < 1. This completes the proof of Theorem 3.5.2.
3.5.3 Stability analysis of endemic equilibrium
Since we now know that the system of equations (3.1)-(3.5) has a unique
endemic equilibrium when R0 > 1, then, to study the stability of the endemic
equilibrium we use the center manifold theory. We begin by renaming the
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variables, i.e., Let T = x1, IL = x2, IA = x3, VI = x4, Z = x5. We also
let β be the bifurcation parameter and
dxl
dt
= fl, for l = 1, 2, 3, 4, 5. Thus,
equations (3.1)-(3.5) can be written as follows:
ẋ1 = π − µx1 − βx1x4, (3.59)
ẋ2 = αβx1x4 − (µ+ γ)x2, (3.60)
ẋ3 = (1− α)βx1x4 + γx2 − (µ+ ω)x2 − σx3x5, (3.61)
ẋ4 = ωNx3 − µvx4, (3.62)
ẋ5 = π1 + β1x3 − µ1x5, (3.63)
with R0 = 1 corresponding to β = β
∗ =
µv(µ+ γ)(µ+ ω + σZ0)
ωNT0[αγ + (µ+ γ)(1− α)]
.
Theorem 3.5.3. The endemic equilibrium is locally asymptotically stable for
R0 > 1 but close to one.
Proof. The linearization matrix of the system of equations (3.59)-(3.63) at a




−µ 0 0 −β∗T0 0
0 −µ− γ 0 αβ∗T0 0
0 γ −µ− ω − σZ0 (1− α)β∗T0 0
0 0 ωN −µv 0




The eigenvalue values obtained from solving a characteristic equation are








(c11 − c12 − c13)2 + 4c14,
(3.65)
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where, c11 = µ + γ, c12 = µ + ω + σZ0, c13 = µv, and c14 = ωN(1 −
α)β∗T0. Noting that λ12,13,14,15 < 0 and λ11 = 0 we can now apply the center
manifold theory to prove the local stability of the endemic equilibrium. The
left eigenvectors associated to the zero eigenvalue of J(E0, β
∗) are obtained
by solving the equation
v[J(E0, β
∗)] = 0, (3.66)
for v = (v1, v2, v3, v4, v5) which gives
v1 = 0, v2 =
γωN
(µ+ γ)(µ+ ω + σZ0)
v4, v3 =
ωN
µ+ ω + σZ0
v4,
v4 = v4 > 0, and v5 = 0.
(3.67)
We can clearly see that v2 > 0 and v3 > 0. The right eigenvectors associated
to the zero eigenvalue of J(E0, β
∗) are obtained by solving the equation
[J(E0, β
∗)]wt = 0, (3.68)
















from which it is clear that, w1 < 0, w2 > 0, w4 > 0 and w5 > 0. Next we
compute the values of a and b in Theorem 2.4.2. Since, v1 = v5 = 0 and
we have no non-linear term(s) in equation (3.62), we will only compute the
partial derivative of f2 and f3. The associated partial derivative with the
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Therefore, a < 0, b > 0 and there exist a supercritical bifurcation at R0 = 1
which means E0 looses stability and E11 as the only equilibrium that exists
when R0 > 1, becomes stable but closer to 1.
3.6 Summary
Through the analysis of the behavior of the model we showed that the con-
stant virus production model was well posed. Hence, the model was used to
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study the dynamics of HIV-1. We calculated reproduction number, which
played a vital role in the analysis of the disease free and endemic equilib-
rium points. We obtained a unique disease free equilibrium point and when
R0 > 1 we obtained a unique endemic equilibrium point. The disease-free
equilibrium point was globally stable when R0 < 1 and the endemic equilib-
rium point was locally asymptotically stable for R0 > 1 but close to 1. We
shall in the following chapter modify this model to incorporate the effects of
Tat and SSu72 and use numerical multi-domain spectral methods to analyze
the model.
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Analysing HIV-1 model
incorporating Tat and Ssu72
proteins
4.1 Introduction
In this chapter we formulate a model incorporating Tat and Ssu72. The
constant virus production model from chapter 3 is modified to incorporate
the extra equations that will capture the dynamics of Tat and Ssu72. We
also discuss the multistage spectral relaxation method and use it to analyze
the HIV-1 model incorporating Tat and Ssu72. In the analysis we look at the
influence of Tat and Ssu72 on the HIV-1 dynamics, i.e., activation of latently
infected CD4+ T cells and the response of CD8+ T cells.
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4.2 Model formulation
Recently it has been discovered that, it is not only the T-cells that drives
the dynamics of HIV-1 but also the existence of the protein called Tat. Ac-
cording to the Salk team [18], HIV-1 cannot live without the existence of
Tat. The Tat protein serves as a HIV-1 scout for suitable environment for
the virus to replicate [18]. When the environment has been discovered, only
then it kicks off the HIV’s transcription to enable the virus to replicate and
spread [18]. The Salk team were able to ascertain that Tat has a mutualistic
partner, Ssu72. Ssu72 plays a key role in activation process of HIV infection
replication, by binding directly to Tat and also builds a feedback loop to
speed up the process [18].
HIV transcription is regulated by the HIV associated Tat. Tat is a transac-
tivator protein that contributes to the transactivation of viral and cellular
genes [26]. Tat protein is produced after the small number of RNA transcrip-
tions of HIV-1 are produced [36]. Tat enhances the transcription of the HIV
dsDNA [35, 36], by binding to the small RNA cellular factors and mediating
the phosphorylation which result in increasing transcription of all HIV genes
[36]. Not only in infection production does the cellular transcription regu-
late HIV LTR driven expression, but also act as a switch to latently infected
cell [36]. These cells serve as a reservoir of infected cells, that prevents the
clearing or eradication of the virus.
The rate of change of the two proteins (Tat and Ssu72) resemble the dynamics
of mutualism. This is due to the fact that each proteins influences the growth
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of the other. We assume the growth of each protein to be saturated. The























r1 and r2 are constant recruitment rates of proteins Tat and Ssu72, respec-
tively. Ktat and KSsu are the carrying capacities of proteins Tat and Ssu72,
respectively. The mutual effects of Tat on Ssu72 and of Ssu72 on Tat are
described by b2 and b1, respectively.
The population of latently infected cells require activation process for them
to be in an actively infectious stage. This is the stage where Tat and Ssu72
play a huge role. These proteins are the bridge from latently infected stage
to actively infectious stage thereby speeding up the activation process.
Incorporating equations (4.1) and (4.2) in the first model will result with the
following systems of equations;
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dT
dt
= π − µT − βTVI , (4.3)
dIL
dt
= αβTVI − (µ+ γ + γ(Ta, Su))IL, (4.4)
dIA
dt




= (ω + ω(Ta))NIA − µvVI , (4.6)
dZ
dt



























is the activation function for









is the killing rate function due to influence of Tat.
The functions (γ, σ, ω) above capture the effects of Tat and Ssu72 on the
HIV-1 dynamics, where φ is the activation rate of latently infected cells by
Tat and Ssu72, φ3 is the lysis rate due to the effects of Tat and φ4 is the killing
rate of infected CD4+ T cells due to the influence of Tat. These functions
were selected in such a way that the assumption of saturation effects of the
two proteins is met.
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4.3 Analysis of Tat and Ssu72 model
In this section we analyse the behaivior of Tat and Ssu72, through studying
the equilibrium points and their stability with respect to equations (4.1) and
(4.2).
4.3.1 Equilibrium points for Tat and Ssu72 dynamics
model
Consider (4.1) and (4.2). This system of two equations have 4 equilibrium
points given by













KSsu. The equilibrium point
(T ∗a , S
∗
u) is biological meaningful if b1b2 < 1.
4.3.2 Stability analysis of equilibria of Tat and Ssu72
dynamics
In this subsection we study the stability of the equilibria given by equation
(4.10)
E∗00 = (0, 0). (4.11)
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Since the Jacobian matrix is a diagonal matrix we can easily deduce that the
two eigenvalues are given by
λ01 = r1, λ02 = r2. (4.13)
Since r1 > 0 and r2 > 0, we therefore conclude that the origin is an unstable
node.























To conclude on the stability of (4.14), we have to show that the following
conditions,
1. tr(J(E∗11)) < 0,
2. det(J(E∗11)) > 0,
hold for
λ2 − tr(J(E∗11))λ+ det(J(E∗11)) = 0, (4.16)
such that its solutions are negative. Now the
tr(J(E∗11)) = −
[
r1(1 + b1) + r2(1 + b2)
1− b1b2
]
< 0, provided b1b2 < 1. (4.17)
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det(J(E∗01)) =
r1r2(1 + b1)(1 + b2)
1− b1b2
> 0, provided b1b2 < 1. (4.18)
Hence, E∗11 is a stable node provided b1b2 < 1.
Finally, we show that the other equilibria are saddle nodes. The Jacobian
matrices at the two equilibria are given by
J(0, KSsu) =







 −r1 r1 KtatKSsu
0 r2(1− b2)
 . (4.20)
Since the eigenvalue of (4.19) and (4.20) are real and opposite signs for b1 < 1
and b2 < 1, we conclude that the equilibrium points for each case ((0, KSsu)
and (Ktat, 0)), are saddle nodes. Otherwise when b1 > 1 and b2 > 1, both
equilibrium points are stable nodes.
4.4 summary
In this chapter we presented an HIV-1 model incorporating Tat and Ssu72.
We analysed the mutualistic model, where we obtained the stability region
for the four equilibrium point obtained. We were able to show that (0, 0) is a
stable node, (0, KSsu) and (Ktat, 0) are saddle nodes when b1 < 1 and b2 < 1,
respectively. However, we also obtained that (0, KSsu) and (Ktat, 0) are also
stable nodes when b1 > 1 and b2 > 1, respectively. We also showed that
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(T ∗a , S
∗
u) is a stable node when b1b2 < 1. In the next chapter we discuss the
numerical method to be used to analyze the developed model in this chapter.





In this chapter we discuss the recent multistage spectral relaxation method
[40], that is used to solve the system of first order differential equations of
initial value problems. Most of the problems of such nature in mathematical
biology cannot be solved analytically, therefore numerical methods have to
be adopted. Various numerical methods to solve such type of problems have
been developed, including, Euler’s method, MatLab built in solvers (ode45,
ode113, ode23), Runge Kutta method and multi-step methods. Some of
these methods have been reported to be disadvantageous for their accuracy,
efficiency, convergence and more over their performance on large interval of
integration [41].
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A vast number of research has been conducted to modify the existing and/or
to develop new methods. Most of these methods have been extended, through
redefining (sub-diving large interval) the interval of integration by construct-
ing multistage methods. The few examples of such methods are; multistage-
homotopy perturbation method [43, 44], multistage variational iteration method
[45], multistage Adomain decomposition method [46], multistage-differential
transform method [47, 48]. However, the use of these methods is computa-
tionally tedious, since the methods seek analytical solutions and they also
suffer from certain limitations such as small convergence [41]. For chaotic
systems some of these methods fail to analytically solve the system [41].
The recent methods that Dlamini et. al. [40] and Motsa et. al. [41], devel-
oped are namely, multistage spectral relaxation method (MSRM), piecewise-
successive linearisation method (PSLM), respectively. These methods have
been shown to solve chaotic systems, e.g., Lorenz, Genesio-Tesi, Rossler,
Chen, Liu, Arneodo-Coullet and the Rikitake system [40, 41, 42]. The MSRM
has been shown to be preffered over PSLM [40]. The computational time of
MSRM against that of PSLM and the decoupling on MSRM against the lin-
earisation on PSLM of the original equations, makes the MSRM efficient to
use and rely on. The MSRM being further compared to MatLab built in
solvers, was shown to be accurate, efficient and reliable [40]. Thus, in this
paper we use MSRM to solve the developed system, which shall be validated
using MatLab built in solvers.
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5.2 Multistage spectral relaxation method
The method to be used to analyze the Model incorporating Tat and Ssu72
is known as multistage spectral relaxation method (MSRM) [40, 42]. The
MSRM is a multistage iterative scheme which is based on blending a Gauss-
Siedel method and spectral collocation integration to decouple and solve,
respectively the system of first order differential equations of initial value
problems. The first derivatives are approximated using the Chebychev spec-
tral method at each collocation point. For accuracy, the interval is then
subdivided into small intervals such that the final value on each interval is
the initial value of the succeeding interval. The nonlinear first order differ-




αr,kxk(t) + fr[x1(t), ..., xm(t)] = gr, (5.1)
xr(0) = x
∗
r, r = 1, 2, ...,m,
where xr are the unknown variables and x
∗
r are the corresponding initial
conditions, αr,k and gr are known constant input parameters and fr is the
nonlinear component of the rth equation, and the dot denotes differentiation
with respect to time t.
The interval of integration is given by t ∈ [0, tF ] from which (5.1) is solved.
This interval is therefore decomposed to sub-interval, Φi = [ti−1, ti], where
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where r = 1, 2, ...,m.
















where r = 1, 2, ...,m and i = 2, 3, ..., F . It may be noted that F denote
the number of intervals to which the solution is to be computed into. From
these sub-intervals, we evaluate the solution to the problem using the pseudo-
spectral collocation method. One may note that the equations are treated
as decoupled system, i.e., a Gauss Siedel Method is used.
5.3 Algorithm
Here, we illustrate the algorithm for the problem (5.3). Equation (5.3) can
be rewritten as a system of equations as follows
ẋir(t) + αr,rx
i
r(t) = gr −
m∑
k=1
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where r = 1, 2, ...,m, i = 1, 2, ..., F and δr,k is a Kronecker delta function
such that
δr,k =
 1, k = r,0, k 6= r. (5.5)
If we let f̂r = gr−
∑m
k=1(1−δr,k)αr,kxik(t)−fr[xi1(t), xi2(t), ..., xim(t)], equation
(5.4) can be compactly written as
ẋir(t) + αr,rx
i










where r = 1, 2, ...,m and i = 1, 2, ..., F . Now, that we have achieved our
results we then solve (5.6) in the first interval, i.e., i = 1
ẋ11,s+1(t) + α1,1x
1



























































, j = 0, 1, ...,M (5.12)
Page 52 of 83
Chapter 5 5.3. Algorithm
being defined as Chebyshev-Gauss-Lobatto collocation points, where the ex-
trema of the Mth order Chebyshev polynomial are given by
TM(τ) = cos(M cos
−1 τ). (5.13)
The linear transformation of the interval [ti−1, ti] to the interval [−1, 1] in







, i = 1, 2, ..., F. (5.14)











where Ar and B
1
r are known term. Thus, we solve for X
1
r,s+1 subject to the


























Xir,s+1 = [x1,s+1, x2,s+1, . . . , x7,s+1]
T (5.18)
with r = 1, 2, ...,m and I is an Identity matrix.
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5.3.1 Application of the MSRM on the model incor-
porating Tat and Ssu72
Consider the following model
Ṫ = π − µT − βTVI ,
İL = αβTVI − (µ+ γ + γ(Ta, Su))IL,
İA = (1− α)βTV + (γ + γ(Ta, Su))IL − (µ+ ω + ω(Ta))IA − (σ + σ(Ta))IAZ,
V̇I = (ω + ω(Ta))NIA − µvVI ,




















with positive parameters and the functions γ(Ta, Su), σ(Ta), ω(Ta) defined
as saturating functions. The dot define the derivative with respect to time.
To solve (5.19), let
x1 = T, x2 = IL, x3 = IA, x4 = VI , x5 = Z, x6 = Ta, x7 = Su, (5.20)
such that (5.19) is rewritten in following form
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ẋ1 = π − µx1 − βx1x4, (5.21)
ẋ2 = αβx1x4 − (µ+ γ + γ(x6, x7))x2, (5.22)
ẋ3 = (1− α)βx1x4 + (γ + γ(x6, x7))x2 − (µ+ ω + ω(x6))x2 − (σ + σ(x6))x3x5,
(5.23)
ẋ4 = (ω + ω(x6))Nx3 − µvx4, (5.24)




















x1(0) > 0, x2(0) ≥ 0, x3(0) ≥ 0, x4(0) ≥ 0, x5(0) > 0, x6(0) ≥ 0, x7(0) ≥ 0.
(5.28)
Page 55 of 83
Chapter 5 5.3. Algorithm
Now if we apply the Gauss Siedel method we obtain
ẋ1,s+1 + µx1,s+1 + βx4,sx1,s+1 = π, (5.29)
ẋ2,s+1 + (µ+ γ + γ(x6,s, x7,s))x2,s+1 = αβx4,sx1,s+1, (5.30)
ẋ3,s+1 + (µ+ ω + ω(x6) + (σ + σ(x6))x5,s)x3,s+1 = (1− α)βx4,sx1,s+1
+ (γ + γ(x6,s, x7,s))x2,s+1, (5.31)
ẋ4,s+1 + µvx4,s+1 = (ω + ω(x6,s))Nx3,s+1, (5.32)
ẋ5,s+1 + µ1x5,s+1 = π1 + β1x3,s+1, (5.33)



























After collocating eqns (5.29)-(5.38) at each point, j = 0, 1, ..., n, we get result
that can be compactly written as
ArXr,s+1 = Br, where r = 1, 2, ..., 7, (5.39)
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D + µI + diag(βx4,s)
D + (µ+ γ)I + diag(γ(x6,s, x7,s))

































Xr,s+1 = [x1,s+1, x2,s+1, . . . , x7,s+1]
T (5.42)
Using the algorithm we solve (5.39) on the interval i = 1, 2, ..., F , subject to
the initial conditions (5.28).
5.4 Summary
In this chapter, a brief introduction and algorithm on the multistage spectral
relaxation method (MSRM) was given. We showed the application of the
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MRSM by solving the developed model in this chapter. In the next chapter
we use the multistage spectral relaxation method to analyze the developed
model.




In this chapter we present the numerical results obtained through solving the
algorithm given in section 5.3. Solutions of the model incorporating Tat and
Ssu72 are compared against the solutions of the model without them. Con-
clusion are then taken based on the behavior of solutions of the two models,
whether there exist variation between the two model or not. We vary the
recruitment rate of CD8+ T cells to test the killing rate of CD8+ T cells
subject to Tat and we vary the initial condition of Tat and Ssu72 to test for
the effects of proteins on activation of resting virus.
We specifically investigate initial condition of Tat and Ssu72 because from
literature we ascertain that Tat and Ssu72 proteins are responsible for ac-
tivation of latently infected CD4+ T cells and replication of the virus. By
varying these aspect, we investigate the role and effect of the two proteins
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on progression of the HIV infection. We seek a threshold value of the two
proteins required to awake the resting virus on the CD4+ T cells. Provided
the threshold is found, then the immune system (cytotoxic killer cells) can
eradicate the actively infectious CD4+ T cells and clear the latent reservoirs.
The solutions of the model are obtained using the multistage spectral relax-
ation method (MSRM). These results are validated using the MatLab built
in solvers (ode45). The chosen number of grid points are M = 10 and five
number of iteration. The interval of integration was chosen to be 300 days,
that is, t ∈ [0, 300], and this interval is divided into 10000 sub-intervals. It
may be noted that these chosen constant gave accurate results in comparison
with the MatLab built in solver (ode45).
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Table 6.1: Estimated values of parameters
Parameters Estimated Values Sources
π 20 Fitted
π1 1 or 10 Fitted
µ 0.02 [17, 39]
µ1 0.1 Fitted
µv 2.4 [17]









φ, φ3,4 1 Estimated
KTa, KSu 30 [23]
The initial conditions are given by T (0) = 1000, IL(0) = 0, IA(0) =
0 and VI(0) = 0.001. Tat and Ssu72 are chosen to be two-tuples from the
values Ta = [0 and 2.0× 10−6] and Su = [0 and 2.0× 10−6] to constitute the
four equilibrium points.
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6.2 Simulation of results: π1 = 1 and π1 = 10
Results (in figures) and discussions are presented for each of the cases on
which the recruitment rate of CD8+ T cells is varied with respect to the
initial conditions of Tat and Ssu72.
6.3 Discussion of results: π1 = 1 and π1 = 10
For each of the four scenarios, we observed that the growth in the virus was
associated with the depletion of uninfected CD4+ T cells and an increase to
infected and infectious compartments. Conversely,decrease in the virus was
associated with the increase in uninfected CD4+ T cells and a decrease to
infected and infectious compartments. In Figures 6.1 and 6.5, after approxi-
mately 50 days of duration of infection, the infected and infectious compart-
ments increases rapidly to reach extrema and then decrease exponentially
to converge to equilibrium values, while CD4+ T cells decreases exponential
and converges to an equilibrium values.
In Figure 6.2 and 6.6, we observe that the CD4+ T cells temporally decreases
but immediately recovers to its initial value, whilst the infected and infectious
classes temporally increase but decays to zero. We observed again that,
compared to cases 1 and 3, cases 2 and 4 of both scenarios when π1 = 1 and
π1 = 10 yields better results in terms of eradicating the latent reservoirs.
What is worth noting is that in cases where Tat is present, latently infected
CD4+ T cells are activated compared to cases where Ssu72 is present alone.
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Case 1: Ta = 0 and Su = 0
Figure 6.1: Results of the model without Tat and Ssu72, when π1 = 1
.
Page 63 of 83
Chapter 6 6.3. Discussion of results: π1 = 1 and π1 = 10
Case 2: Ta = 2.0× 10−6 and Su = 0
Figure 6.2: Results of the model without Ssu72, when π1 = 1.
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Case 3: Ta = 0 and Su = 2.0× 10−6
Figure 6.3: Results of the model without Tat, when π1 = 1.
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Case 4: Ta = 2.0× 10−6 and Su = 2.0× 10−6
Figure 6.4: Results of the model with Tat and Ssu72, when π1 = 1.
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Case 1: Ta = 0 and Su = 0
Figure 6.5: Results of the model without Tat and Ssu72, when π1 = 10.
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Case 2: Ta = 2.0× 10−6 and Su = 0
Figure 6.6: Results of the model without Ssu72, when π1 = 10.
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Case 3: Ta = 0 and Su = 2.0× 10−6
Figure 6.7: Results of the model without Tat, when π1 = 10.
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Case 4: Ta = 2.0× 10−6 and Su = 2.0× 10−6
Figure 6.8: Results of the model with Tat and Ssu72, when π1 = 10.
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We observe in Figure 6.4 and 6.8 that, the two proteins enhance the growth
of one another to their maximum values. This in turn causes a more rapid
depletion of IL compared to a case of Tat being present alone consequently,
leading to the decrease of viral load decaying to zero. In conclusion, the
results suggest that, in the presence of Tat and Ssu72, there is a possibility
of wiping out the IL, virus and recovery of healthy CD4
+ T cells. We can
therefore, infer that Tat and Ssu72 causes a transition from an endemic equi-
librium state to a disease free equilibrium state.
In the presence of Tat, the increase in the effects of CD8+ T cells leads to
the significant decrease in viral latent cells and increase in the healthy CD4+
T cells. For case 4, a similar conclusion to case 2 can be reached but there
is much more significant decrease in viral load and latently infected CD4+
T cells and best restoration of healthy CD4+ T cells. Hence, the combined
effects of Tat and Ssu72 are more significant than the sole effect of each of
them.
6.4 Summary
In this chapter we achieved to address the motivation of the study through the
analysis of the model presented in chapter 4. Multistage spectral relaxation
method was used to analyze the model. Results obtained through MSRM
were verified against results obtained through MatLab built-in solver ode45.
Figure presenting resulting were presented for cases where we vary the initial
conditions for Tat and Ssu72 and also the recruitment rate of CD8+ T cells.
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It was shown that the mutualistic combination of Tat and Ssu72 has more
significant effect on activation of latently CD4+ T cells than the sole effect
of each of them. In the following chapter we give a discussion and conclusion
of results presented in chapter 6.
Page 72 of 83
Chapter 7
Discussion and conclusion
It is known to date that there is no vaccine to cure HIV-1 infection but rather
the antiretroviral drug is used instead. HAART helps to keep the HIV-1 in-
fection in chronic stage and can clear off the infectious virus to undetectable
viral load. The challenge with HAART is that it does not target latently
infected CD4+ T cells, hence the HIV-1 infection is not eradicated in an in-
fected individual. Thus in this study we have focused on the Tat and Ssu72
known to be responsible for activating the latent virus resting on the CD4+
T cells. The motivation of this study was to study the effects of Tat and
Ssu72 on the activation of latently infected CD4+ T cells and the response
of immune system.
In chapter 3 we formulated a constant virus production model to capture the
dynamics of the HIV-1 infection. The model was shown to be well posed and
its solutions to be biologically meaningful. Through analysis of this model
we derived threshold to which the infection free and endemic states are glob-
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ally stable. For the public health officials these thresholds are critical. They
can check which parameters to concentrate onto to develop efficient inter-
ventions. On the other hand, one could be interested in the transition of
endemic state to disease free state or vice versa, which could be attained
through the knowledge of the reproduction number.
The results in chapter 3 suggested that an infected individual will remain
infected as long as R0 > 1 and can only be free from a disease when R0 ≤ 1.
It was also attained that parameters like γ, ω and σ should be considered
for transition of endemic state to infection free state. Tat and Ssu72 were
known to affect these parameters. In chapter 4 we incorporated Tat and
Ssu72 on these parameters to construct activation function, killing rate func-
tion and lysis burst function. Imposing these functions on the constant virus
production model and combining the resulting model with the system of two
equations that captures the role of the Tat and Ssu72, we were able to for-
mulate a model that explains the dynamics of HIV-1 infection better.
In chapter 5, presented an introduction and algorithm of the multistage spec-
tral relaxation method and it was used to analyzed the model presented in
chapter 4. This method was recently proposed by Dlamini et al. It was shown
to be accurate and reliable. We adopted its in our analysis to demonstrate
it accuracy against the well know ode45 MatLab built in it solver. The two
methods worked well. Therefore, we can conclude that the results presented
in chapter 6 are correct with respect to the structure of the model, parameter
and initial values used.
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In chapter 6 we investigated the effects of Tat and Ssu72 and the recruit-
ment rate of CD8+ T cells. We noted that in absence of the two protein or
of Tat, the latently infected CD4+ T cells were not eradicated irrespective of
number of CD8+ T cells present in the immune system. Hence, the infection
progresses in an infected individual. However, in the presence of Tat alone
or Tat and Ssu72, the results showed that latently infected and the actively
infectious CD4+ T cells and the can be eradicated in an infected individual
through the response of CD8+ T cells whilst the healthy CD4+ T cells are
restored. This result agreed with the assertion in literature, that the erad-
ication of HIV-1 could be achieved by eradicating latent reservoirs. Most
importantly, these results shown that the interplay between Tat and Ssu72
can activate the virus resting virus in CD4+ T cells.
7.1 Conclusion
The results suggested that Tat has much influence on the activation of la-
tently infected CD4+ T cells and the killing of infectious infected CD4+ T
cells compared to Ssu72. Better effects of Tat can be realised when its func-
tions are enhanced with Ssu72. These results support the findings by a vast
number of research, that suggested the activation of resting virus to be a
solution to eradication of the HIV infection in an infected individual.
Results do not only show that the viral load could be decreased to zero but
they show as well that these proteins can enhance the growth of uninfected
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CD4+ T cells. We therefore recommend that intervention strategies should
be developed that target to enhance the mutual effects of Tat and Ssu72 in
activating the latently CD4+ T cells. Such interventions should not be used
in solitude but in a combination with other effective strategies such as using
HAART.
7.2 Further work
From these results, stochastic models can be adopted as the alternative ap-
proach to predict the probabilities of infection progression once the virus is
introduced into an individual. This aspect makes the models more realistic.
Further, using these results as a building blocks to strategies of activation of
latent cells, a number of aspects may be incorporated to improve the model,
Tat can be manifested as both intracellular or extracellular. In the current
study, we only consider intracellular Tat. Incorporating the dynamics of ex-
tracellular Tat will also enrich the modeling of activation of latently infected
CD4+ T cell dynamics.
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